Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis.
Assay development and inhibition of the Mt-DprE2 essential reductase from Mycobacterium tuberculosis.
复制标题
DOI:
10.1099/mic.0.001288
复制
发表时间:
2023-01
期刊:
影响因子:
2.8
通讯作者:
Besra, Gurdyal S.
中科院分区:
文献类型:
--
作者:
Batt, Sarah M.;Toth, Szilvi;Rodriguez, Beatriz;Abrahams, Katherine A.;Veerapen, Natacha;Chiodarelli, Giacomo;Cox, Liam R.;Moynihan, Patrick J.;Lelievre, Joel;Futterer, Klaus;Besra, Gurdyal S.
关键词:
DprE2 is an essential enzyme in the synthesis of decaprenylphosphoryl-β-d-arabinofuranose (DPA) and subsequently arabinogalactan, and is a significant new drug target for M. tuberculosis . Two compounds from the GSK-177 box set, GSK301A and GSK032A, were identified through Mt-DprE2-target overexpression studies. The Mt-DprE1-DprE2 complex was co-purified and a new in vitro DprE2 assay developed, based on the oxidation of the reduced nicotinamide adenine dinucleotide cofactor of DprE2 (NADH/NADPH). The Mt-DprE1-DprE2 complex showed interesting kinetics in both the DprE1 resazurin-based assay, where Mt-DprE2 was found to enhance Mt-DprE1 activity and reduce substrate inhibition; and also in the DprE2 assay, which similarly exhibited substrate inhibition and a difference in kinetics of the two potential cofactors, NADH and NADPH. Although, no inhibition was observed in the DprE2 assay by the two GSK set compounds, spontaneous mutant generation indicated a possible explanation in the form of a pro-drug activation pathway, involving fgd1 and fbiC.
登录
查看更多内容
DOI:
10.1073/pnas.0508392103
发表时间:
2006-01-10
影响因子:
11.1
作者:
Manjunatha, UH;Boshoff, H;Barry, CE
通讯作者:
Barry, CE
影响因子:
3.7
作者:
Jose Rebollo-Lopez, Maria;Lelievre, Joel;Barros-Aguire, David
通讯作者:
Barros-Aguire, David
影响因子:
3.6
作者:
Kolly, Gaelle S.;Boldrin, Francesca;Cole, Stewart T.
通讯作者:
Cole, Stewart T.
影响因子:
4.4
作者:
Carroll, Paul;Faray-Kele, Marie-Claire;Parish, Tanya
通讯作者:
Parish, Tanya
影响因子:
3.7
作者:
Crellin, Paul K.;Brammananth, Rajini;Coppel, Ross L.
通讯作者:
Coppel, Ross L.